Vitura HealthASX:VIT Days Payable is 42.22 as of Dec. 2025, which is 5% above its 10-year median of 40.13. The stock has 8 warning signs investors should review. Among 922 Drug Manufacturers companies, Vitura Health ranks worse than 79.61% on this metric.
The historical rank and industry rank for Vitura Health's Days Payable or its related term are showing as below:
ASX:VIT'
s Days Payable Range Over the Past 10 Years
Min: 27.96 Med: 40.13 Max: 42678.93
Current: 44.94
During the past 7 years, Vitura Health's highest Days Payable was 42678.93. The lowest was 27.96. And the median was 40.13.
ASX:VIT's Days Payable is ranked worse than 79.61% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs ASX:VIT: 44.94
Vitura Health's Days Payable
declined
from Dec. 2024 (44.94) to Dec. 2025 (42.22).
It may suggest that Vitura Healthaccelerated paying its suppliers.
Vitura Health Days Payable Related Terms
Vitura Health Days Payable Historical Data
* Premium members only.
The historical data trend for Vitura Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitura Health Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vitura Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Vitura Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vitura Health's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitura Health (ASX:VIT) has a Days Payable of 42.22 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vitura Health and its competitors. This is near median its historical median of 40.13. Over the past decade, Vitura Health's Days Payable has ranged from 27.96 to 42,678.93. According to the industry distribution chart, Vitura Health ranks #734 out of 922 companies in the Drug Manufacturers industry, placing it in the top 79.6%.
Is Vitura Health's Days Payable too high?
Vitura Health's current Days Payable of 42.22 is near median its 10-year median of 40.13. Over the past 10 years, this metric has ranged from a low of 27.96 to a high of 42,678.93. The Drug Manufacturers industry median Days Payable is 90.61. Vitura Health's value of 42.22 is 53.4% below this industry median. Based on the distribution chart, Vitura Health ranks #734 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Vitura Health's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vitura Health ranks #734 out of 922 companies for Days Payable. This places Vitura Health in the lower half of its industry. The industry median Days Payable is 90.61. Vitura Health's value of 42.22 is 53.4% below this benchmark. Historically, Vitura Health's own Days Payable has ranged from 27.96 to 42,678.93 over the past decade. While the company's 10-year median is 40.13 vs. the industry median of 90.61, Vitura Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitura Health's current Days Payable of 42.22 is 53.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vitura Health and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitura Health's current Days Payable is 42.22, which is near median its own 10-year median of 40.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitura Health stock overvalued right now?
Based on GuruFocus' analysis, Vitura Health (ASX:VIT) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.03 — trading 73% below its estimated fair value. The current Days Payable is 42.22, which is near median its 10-year median of 40.13 and 53.4% below the Drug Manufacturers industry median of 90.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vitura Health (ASX:VIT), the current Days Payable is 42.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VIT has been successfully added to your 